🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11779+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11779 recruiting trials

Phase 1RecruitingNCT06554301

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

🏥 China National Center for Cardiovascular Diseases📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06458257

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

🏥 Ruijin Hospital📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06077591

Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors

👨‍⚕️ James Lau, Prince of Wales Hospital📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06586138

Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test

🏥 Hospices Civils de Lyon📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06623032

Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals

👨‍⚕️ Andreas M Fritzen, Associate Professor, University of Copenhagen📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT07314268

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

🏥 University of Sao Paulo General Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06475235

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

👨‍⚕️ Lakshmi Nayak, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06544499

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

🏥 argenx📍 94 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06899399

Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis

👨‍⚕️ Feng Gao, MD, Beijing Tiantan Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06742515

Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL

🏥 First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06585514

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

🏥 Beijing GoBroad Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT06559176

A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )

🏥 Prime Medicine, Inc.📍 5 sites📅 Started Oct 2024View details ↗
EARLY_Phase 1RecruitingNCT07066085

Serial Blood Count Study

👨‍⚕️ David C. Dale, MD, University of Washington📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06660121

Electrochemotherapy for Desmoid Tumors

👨‍⚕️ Giancarlo Facchini, Medicine and Surgery, IRCCS Istituto Ortopedico Rizzoli📍 1 site📅 Started Oct 2024View details ↗
Phase 4RecruitingNCT06903221

A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection

🏥 Dimitri Diavatopoulos📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06484348

Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia

👨‍⚕️ Laure PETER-DEREX, MD-PhD, Hospices Civils de Lyon📍 2 sites📅 Started Oct 2024View details ↗
Phase 4RecruitingNCT06353126

DEB-TACE Prior to Liver Transplantation in the Treatment of HCC

👨‍⚕️ Jianjun Zhang, MD, RenJi Hospital📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06539624

Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

👨‍⚕️ Jianhua Mao, PhD, Children's Hospital, Zhejiang University School of Medicine📍 2 sites📅 Started Oct 2024View details ↗
Phase 2, PHASE3RecruitingNCT06055959

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

👨‍⚕️ UCB Cares, 001 844 599 2273📍 9 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06714838

Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

🏥 Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 222 of 589Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →